Aristotle Capital Management LLC Cuts Stock Holdings in Corteva, Inc. $CTVA

Aristotle Capital Management LLC decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 4.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,041,806 shares of the company’s stock after selling 972,316 shares during the period. Corteva comprises approximately 2.7% of Aristotle Capital Management LLC’s holdings, making the stock its 5th largest holding. Aristotle Capital Management LLC’s holdings in Corteva were worth $1,423,062,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Brighton Jones LLC grew its holdings in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the last quarter. Woodline Partners LP lifted its holdings in Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after buying an additional 16,644 shares in the last quarter. Candriam S.C.A. lifted its holdings in Corteva by 0.8% during the 2nd quarter. Candriam S.C.A. now owns 35,209 shares of the company’s stock valued at $2,624,000 after buying an additional 279 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. boosted its position in Corteva by 312.4% in the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 86,812 shares of the company’s stock valued at $6,469,000 after buying an additional 65,760 shares during the period. Finally, Foundations Investment Advisors LLC grew its stake in Corteva by 6.3% in the 2nd quarter. Foundations Investment Advisors LLC now owns 5,165 shares of the company’s stock worth $385,000 after acquiring an additional 305 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.14% of the stock is owned by insiders.

Corteva Price Performance

CTVA opened at $79.13 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The firm has a market capitalization of $53.22 billion, a PE ratio of 50.08, a price-to-earnings-growth ratio of 2.71 and a beta of 0.72. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $80.90. The business’s 50-day moving average is $74.11 and its two-hundred day moving average is $69.21.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same period in the previous year, the business earned $0.32 EPS. The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is 45.57%.

Analysts Set New Price Targets

CTVA has been the topic of a number of research reports. Argus raised shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Royal Bank Of Canada lifted their target price on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Finally, JPMorgan Chase & Co. downgraded Corteva from an “overweight” rating to a “neutral” rating and increased their price target for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.